Imprinted silencing of Slc22a2 and Slc22a3 does not need transcriptional overlap between Igf2r and Air

被引:72
|
作者
Sleutels, F
Tjon, G
Ludwig, T
Barlow, DP [1 ]
机构
[1] OAW, Inst Mol Biol, Vienna, Austria
[2] Netherlands Canc Inst, Dept Mol Genet, Amsterdam, Netherlands
[3] Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA
来源
EMBO JOURNAL | 2003年 / 22卷 / 14期
关键词
genomic imprinting; Igf2r; non-coding RNA; Slc22a2; Slc22a3;
D O I
10.1093/emboj/cdg341
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Silencing of the paternal allele of three imprinted genes (Igf2r, Slc22a2 and Slc22a3) requires cis expression of the Air RNA that overlaps the promoter of one of them (Igf2r). Air is a non-coding RNA whose mode of action is unknown. We tested the role of the Igf2r promoter and the role of transcriptional overlap between Igf2r and Air in silencing in this cluster. We analyzed imprinted expression in mice in which the Igf2r promoter is replaced by a thymidine kinase promoter that preserves a transcription overlap with Air, and in mice with a deleted Igf2r promoter that lack any transcriptional overlap with Air. Imprinted silencing of Air, Slc22a2 and Slc22a3 is maintained by the replacement promoter and also in the absence of transcriptional overlap with Air. These results exclude a role for the Igf2r promoter and for transcriptional overlap between Igf2r and Air in silencing Air, Slc22a2 and Slc22a3. Although these results do not completely exclude a role for a double-stranded RNA silencing mechanism, they do allow the possibility that the Air RNA has intrinsic cis silencing properties.
引用
收藏
页码:3696 / 3704
页数:9
相关论文
共 29 条
  • [1] Placental imprinting of SLC22A3 in the IGF2R imprinted domain is conserved in therian mammals
    Ishihara, Teruhito
    Griffith, Oliver W.
    Suzuki, Shunsuke
    Renfree, Marilyn B.
    EPIGENETICS & CHROMATIN, 2022, 15 (01)
  • [2] Placental imprinting of SLC22A3 in the IGF2R imprinted domain is conserved in therian mammals
    Teruhito Ishihara
    Oliver W. Griffith
    Shunsuke Suzuki
    Marilyn B. Renfree
    Epigenetics & Chromatin, 15
  • [3] Human Organic Cation Transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as Disposition Pathways for Fluoroquinolone Antimicrobials
    Mulgaonkar, Aditi
    Venitz, Juergen
    Gruendemann, Dirk
    Sweet, Douglas H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2705 - 2711
  • [4] Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension
    Sallinen, Riitta
    Kaunisto, Mari A.
    Forsblom, Carol
    Thomas, Merlin
    Fagerudd, Johan
    Pettersson-Fernholm, Kim
    Groop, Per-Henrik
    Wessman, Maija
    ANNALS OF MEDICINE, 2010, 42 (04) : 296 - 304
  • [5] Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
    Al-Eitan, Laith N.
    Almomani, Basima A.
    Nassar, Ahmad M.
    Elsaqa, Barakat Z.
    Saadeh, Nesreen A.
    JOURNAL OF PERSONALIZED MEDICINE, 2019, 9 (01):
  • [6] Interaction of H2-antagonists with human organic cation transporters hOCT1 (SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
    Bourdet, DL
    Pritchard, JB
    Thakker, DR
    DRUG METABOLISM REVIEWS, 2004, 36 : 262 - 262
  • [7] Airn Transcriptional Overlap, But Not Its lncRNA Products, Induces Imprinted Igf2r Silencing
    Latos, Paulina A.
    Pauler, Florian M.
    Koerner, Martha V.
    Senergin, H. Basak
    Hudson, Quanah J.
    Stocsits, Roman R.
    Allhoff, Wolfgang
    Stricker, Stefan H.
    Klement, Ruth M.
    Warczok, Katarzyna E.
    Aumayr, Karin
    Pasierbek, Pawel
    Barlow, Denise P.
    SCIENCE, 2012, 338 (6113) : 1469 - 1472
  • [8] Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
    Yang, Jian
    Kalogerou, Maria
    Gallacher, John
    Sampson, Julian R.
    Shen, Ming Hong
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1479 - 1490
  • [9] Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
    Bourdet, DL
    Pritchard, JB
    Thakker, DR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1288 - 1297
  • [10] Genetic analysis of the organic cation transporter genes Orct2/Slc22a2 and Orct3/Slc22a3 reduces the critical region for the t haplotype mutant tw73 to 200 kb
    Zwart, R
    Verhaagh, S
    de Jong, J
    Lyon, M
    Barlow, DP
    MAMMALIAN GENOME, 2001, 12 (09) : 734 - 740